One of Only 10 Startups Chosen from 86 Applicants to Pitch Before Leading Central European MedTech Investors
Lund, Sweden, May 6, 2025 – MedVasc was selected to present at MedTech Pitch Day 2025, hosted by High-Tech Gründerfonds (HTGF), Germany’s largest investment fund for early-stage startups.
Out of 86 high-potential MedTech applicants from across Europe, only 10 startups were invited to pitch at the exclusive event, which was held at Dräger in Lübeck, Germany. The gathering brought together top-tier MedTech investors and industry leaders from Central Europe for a day of cutting-edge innovation and strategic networking.
“We are honored to have been selected for MedTech Pitch Day 2025 by HTGF,” said Cathrin Johansson, CEO of MedVasc. “Being recognized among Europe’s most promising MedTech startups validates our team’s hard work and vision to transform vascular interventions for the better.”
About MedVasc
MedVasc is a MedTech company developing next-generation vascular access technologies for minimally invasive procedures. Founded in [Year] and based in Copenhagen, Denmark, MedVasc is committed to improving outcomes for patients and simplifying complex interventions for healthcare professionals.
About HTGF
High-Tech Gründerfonds (HTGF) is Germany’s leading seed investor, supporting high-potential tech startups with early-stage funding and strategic guidance. Since its founding, HTGF has financed over 700 startups across sectors including life sciences, digital health, and medical devices.
About Dräger
Dräger is a leading international company in the fields of medical and safety technology. Founded in Lübeck in 1889, Dräger has grown into a worldwide, DAX-listed enterprise in its fifth generation as a family-run business.
For more information, please contact:
Cathrin Johansson, CEO, MedVasc AB
